Pharmexcil flags export disruption risk due to COPP mandate; seeks urgent review

The Pharmaceuticals Export Promotion Council of India on Friday sought a review of a recent circular issued by the Central Drugs Standard Control Organisation, which mandates exclusive online submission of…

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…